Prevention of POV After Paediatric Tonsillectomy

Status Completed

Clinical Trial Summary

Tonsillectomy is one of the most frequently performed surgical procedures in children. It remains associated with a high morbidity related to postoperative vomiting (POV), pain, risk of bleeding, and dehydration due to impaired oral intake. Current medications for POV have limited efficacy and may even be associated with potential side-effects. Non-pharmacological techniques such as acupuncture has been investigated as alternatives to antiemetics and as additional treatment modalities for POV.

Clinical Trial Description

Postoperative vomiting (POV) is one of the most common complication in children undergoing tonsillectomy. Its incidence is between 62% and 73% when no prophylactic antiemetic is given. Because of Limited efficacy and side effects with antiemetics, many alternative treatment had been used. Acupuncture is simple, inexpensive, and noninvasive with minimal side effects. The objective of this study is to compare two prophylactic antiemetic treatments :

- Dexamethasone (0.15 mg/kg) immediately after induction of anaesthesia

- Acupuncture treatment (immediately after induction of anaesthesia and for approximately 20 minutes) ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Vomiting

Clinical Trial Details

NCT number	NCT02387918
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	Phase 4
Start date	February 2015
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00358813` - Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment	Phase 1
Recruiting	`NCT03851835` - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis	Phase 3
Terminated	`NCT01649258` - Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy	Phase 1
Terminated	`NCT01975727` - Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting	Phase 2
Completed	`NCT02939287` - Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan	Phase 3
Not yet recruiting	`NCT06464926` - Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)	N/A
Completed	`NCT02462811` - A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)	Phase 3
Recruiting	`NCT01966406` - Is Nasogastric Tube Necessary After Pancreaticoduodenectomy?	N/A
Completed	`NCT01007500` - Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery	Phase 4
Recruiting	`NCT00528554` - Laser Acupuncture Against Nausea in Children	N/A
Completed	`NCT00537875` - Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens	N/A
Completed	`NCT00394966` - A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)	Phase 2
Completed	`NCT00177333` - Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens	Phase 4
Completed	`NCT00946387` - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00947128` - To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions	Phase 1
Not yet recruiting	`NCT04827108` - Psychometric Properties of the Chinese Version of PeNAT
Not yet recruiting	`NCT04853303` - VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK	N/A
Recruiting	`NCT03679182` - Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care	Phase 2
Terminated	`NCT01405924` - Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030)	Phase 2
Recruiting	`NCT04116697` - A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan	N/A